Getz Pharma started its operation in Sri Lanka in the year 2002 and is ranked as one of the fastest growing pharmaceutical companies in Sri Lanka by IMS for the last three years. Our annual average growth rate in Sri Lanka is 93.66 %, which is 11 times higher than that of the industry.

Getz Pharma is operating in Sri Lanka with a highly motivated and dedicated marketing and sales team, which has led the company to out-pace the industry’s growth. We have strong coverage both in terms of doctors and pharmacies all over Sri Lanka and are associated with the largest pharmaceutical distributor “Hemas Pharmaceuticals” for the distribution of our products in Sri Lanka.

We have more than 21 brands in Sri Lanka in the following therapeutic segments:

• Cardiovascular
• Diabetes
• Infectious Diseases
• Pulmonology
• Pediatrics
• Hepatology
• Gastroenterology
• Anti-Rheumatics

Our marketing philosophy is to be brand leader in every molecule within three years of launch. We have brand leadership in seven molecules so far and many others will achieve the leadership in the coming years.

Our regulatory team for Sri Lanka possesses in-depth understanding and knowledge of regulatory requirements of the CDDA (Cosmetics, Devices and Drugs Authority) of Sri Lanka, which enables Getz Pharma to produce and submit the high quality dossiers that comply with updated guidelines; this ensures the registration of products in shortest possible time.

Our vision in the Sri Lanka market is to be one of the top 10 pharmaceutical companies by 2010. We will continue to introduce innovative molecules at a rapid pace in the Sri Lankan market and to focus on building strong brands.